Federated Hermes, Inc. Harrow Health, Inc. Transaction History

Federated Hermes, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$13.84 - $21.46 $567 - $879	41 New	41 $0
Q1 2022 May 13, 2022	SELL	$6.77 - $8.66 $528 - $675	-78 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $357 - $504	-42 Reduced 35.0%	78 $1,000
Q3 2021 Nov 15, 2021	BUY	$6.99 - $10.6 $349 - $530	50 Added 71.43%	120 $1,000
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $467 - $774	70 New	70 $1,000
Q2 2019 Aug 14, 2019	SELL	$4.2 - $8.7 $407 - $843	-97 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$4.75 - $7.1 $460 - $688	97 New	97 $1,000

174

21.2M

844K

698K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $854M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.